-
1
-
-
79957955614
-
NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism
-
Burgos ES (2011). NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism. Curr Med Chem 18, 1947-1961.
-
(2011)
Curr Med Chem
, vol.18
, pp. 1947-1961
-
-
Burgos, E.S.1
-
2
-
-
0020677595
-
Biochemistry of tryptophan in health and disease
-
Bender DA (1983). Biochemistry of tryptophan in health and disease. Mol Aspects Med 6, 101-197.
-
(1983)
Mol Aspects Med
, vol.6
, pp. 101-197
-
-
Bender, D.A.1
-
3
-
-
0038614824
-
Enzymatic synthesis of nicotinamide mononucleotide
-
Preiss J and Handler P (1957). Enzymatic synthesis of nicotinamide mononucleotide. J Biol Chem 225, 759-770.
-
(1957)
J Biol Chem
, vol.225
, pp. 759-770
-
-
Preiss, J.1
Handler, P.2
-
4
-
-
0035145516
-
Identification of a plasmidencoded gene from Haemophilus ducreyi which confers NAD independence
-
Martin PR, Shea RJ, and Mulks MH (2001). Identification of a plasmidencoded gene from Haemophilus ducreyi which confers NAD independence. J Bacteriol 183, 1168-1174.
-
(2001)
J Bacteriol
, vol.183
, pp. 1168-1174
-
-
Martin, P.R.1
Shea, R.J.2
Mulks, M.H.3
-
5
-
-
77954248039
-
Altered metabolism in cancer
-
Locasale J and Cantley L (2010). Altered metabolism in cancer. BMC Biol 8, 88.
-
(2010)
BMC Biol
, vol.8
, pp. 88
-
-
Locasale, J.1
Cantley, L.2
-
6
-
-
0023095505
-
Pyridine nucleotide cycling and poly(ADP-ribose) synthesis in resting human lymphocytes
-
Carson DA, Seto S, and Wasson DB (1987). Pyridine nucleotide cycling and poly(ADP-ribose) synthesis in resting human lymphocytes. J Immunol 138, 1904-1907.
-
(1987)
J Immunol
, vol.138
, pp. 1904-1907
-
-
Carson, D.A.1
Seto, S.2
Wasson, D.B.3
-
7
-
-
0034074057
-
Enhancement of poly-adenosine diphosphateribosylation in human hepatocellular carcinoma
-
Nomura F, Yaguchi M, Togawa A, Miyazaki M, Isobe K, Miyake M, Noda M, and Nakai T (2000). Enhancement of poly-adenosine diphosphateribosylation in human hepatocellular carcinoma. J Gastroenterol Hepatol 15, 529-535.
-
(2000)
J Gastroenterol Hepatol
, vol.15
, pp. 529-535
-
-
Nomura, F.1
Yaguchi, M.2
Togawa, A.3
Miyazaki, M.4
Isobe, K.5
Miyake, M.6
Noda, M.7
Nakai, T.8
-
8
-
-
77953408297
-
A preclinical study on the rescue of normal tissue by nicotinic acid in high-dose treatment with APO866, a specific nicotinamide phosphoribosyltransferase inhibitor
-
Olesen UH, Thougaard AV, Jensen PB, and Sehested M (2010). A preclinical study on the rescue of normal tissue by nicotinic acid in high-dose treatment with APO866, a specific nicotinamide phosphoribosyltransferase inhibitor. Mol Cancer Ther 9, 1609-1617.
-
(2010)
Mol Cancer Ther
, vol.9
, pp. 1609-1617
-
-
Olesen, U.H.1
Thougaard, A.V.2
Jensen, P.B.3
Sehested, M.4
-
9
-
-
70449212074
-
Biosynthesis of diphosphopyridine nucleotide. I. Identification of intermediates
-
Preiss J and Handler P (1958). Biosynthesis of diphosphopyridine nucleotide. I. Identification of intermediates. J Biol Chem 233, 488-492.
-
(1958)
J Biol Chem
, vol.233
, pp. 488-492
-
-
Preiss, J.1
Handler, P.2
-
10
-
-
79954878322
-
Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas
-
Olesen UH, Hastrup N, and Sehested M (2011). Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas. APMIS 119, 296-303.
-
(2011)
APMIS
, vol.119
, pp. 296-303
-
-
Olesen, U.H.1
Hastrup, N.2
Sehested, M.3
-
11
-
-
70350538957
-
The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: Strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors
-
Watson M, Roulston A, Bélec L, Billot X, Marcellus R, Bédard D, Bernier C, Branchaud S, Chan H, Dairi K, et al. (2009). The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors. Mol Cell Biol 29, 5872-5888.
-
(2009)
Mol Cell Biol
, vol.29
, pp. 5872-5888
-
-
Watson, M.1
Roulston, A.2
Bélec, L.3
Billot, X.4
Marcellus, R.5
Bédard, D.6
Bernier, C.7
Branchaud, S.8
Chan, H.9
Dairi, K.10
-
12
-
-
38149105811
-
The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor
-
Holen K, Saltz LB, Hollywood E, Burk K, and Hanauske AR (2008). The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor. Invest New Drugs 26, 45-51.
-
(2008)
Invest New Drugs
, vol.26
, pp. 45-51
-
-
Holen, K.1
Saltz, L.B.2
Hollywood, E.3
Burk, K.4
Hanauske, A.R.5
-
13
-
-
14844291424
-
Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: An ECSG/EORTC study
-
Ravaud A, Cerny T, Terret C, Wanders J, Bui BN, Hess D, Droz JP, Fumoleau P, and Twelves C (2005). Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study. Eur J Cancer 41, 702-707.
-
(2005)
Eur J Cancer
, vol.41
, pp. 702-707
-
-
Ravaud, A.1
Cerny, T.2
Terret, C.3
Wanders, J.4
Bui, B.N.5
Hess, D.6
Droz, J.P.7
Fumoleau, P.8
Twelves, C.9
-
14
-
-
0014960271
-
Uptake and metabolism of nicotinic acid by human blood platelets. Effects of structure analogs and metabolic inhibitors
-
Gaut ZN and Solomon HM (1970). Uptake and metabolism of nicotinic acid by human blood platelets. Effects of structure analogs and metabolic inhibitors. Biochim Biophys Acta 201, 316-322.
-
(1970)
Biochim Biophys Acta
, vol.201
, pp. 316-322
-
-
Gaut, Z.N.1
Solomon, H.M.2
-
15
-
-
84883140710
-
Structure-based discovery of novel amide-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitors
-
Zheng X, Bauer P, Baumeister T, Buckmelter AJ, Caligiuri M, Clodfelter KH, Han B, Ho YC, Kley N, Lin J, et al. (2013). Structure-based discovery of novel amide-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitors. J Med Chem 56, 6413-6433.
-
(2013)
J Med Chem
, vol.56
, pp. 6413-6433
-
-
Zheng, X.1
Bauer, P.2
Baumeister, T.3
Buckmelter, A.J.4
Caligiuri, M.5
Clodfelter, K.H.6
Han, B.7
Ho, Y.C.8
Kley, N.9
Lin, J.10
-
16
-
-
84884281888
-
Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)
-
Zheng X, Bair KW, Bauer P, Baumeister T, Bowman KK, Buckmelter AJ, Caligiuri M, Clodfelter KH, Feng Y, Han B, et al. (2013). Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). Bioorg Med Chem Lett 23, 5488-5497.
-
(2013)
Bioorg Med Chem Lett
, vol.23
, pp. 5488-5497
-
-
Zheng, X.1
Bair, K.W.2
Bauer, P.3
Baumeister, T.4
Bowman, K.K.5
Buckmelter, A.J.6
Caligiuri, M.7
Clodfelter, K.H.8
Feng, Y.9
Han, B.10
-
17
-
-
79960403317
-
Pharmacokinetic-pharmacodynamic analysis of vismodegib in preclinical models of mutational and ligand-dependent Hedgehog pathway activation
-
Wong H, Alicke B, West KA, Pacheco P, La H, Januario T, Yauch RL, de Sauvage FJ, and Gould SE (2011). Pharmacokinetic-pharmacodynamic analysis of vismodegib in preclinical models of mutational and ligand-dependent Hedgehog pathway activation. Clin Cancer Res 17, 4682-4692.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 4682-4692
-
-
Wong, H.1
Alicke, B.2
West, K.A.3
Pacheco, P.4
La, H.5
Januario, T.6
Yauch, R.L.7
de Sauvage, F.J.8
Gould, S.E.9
-
18
-
-
0031900171
-
Noninvasive methods for quantitating blood time-activity curves from mouse PET images obtained with fluorine-18-fluorodeoxyglucose
-
Green LA, Gambhir SS, Srinivasan A, Banerjee PK, Hoh CK, Cherry SR, Sharfstein S, Barrio JR, Herschman HR, and Phelps ME (1998). Noninvasive methods for quantitating blood time-activity curves from mouse PET images obtained with fluorine-18-fluorodeoxyglucose. J Nucl Med 39, 729-734.
-
(1998)
J Nucl Med
, vol.39
, pp. 729-734
-
-
Green, L.A.1
Gambhir, S.S.2
Srinivasan, A.3
Banerjee, P.K.4
Hoh, C.K.5
Cherry, S.R.6
Sharfstein, S.7
Barrio, J.R.8
Herschman, H.R.9
Phelps, M.E.10
-
19
-
-
84861629157
-
Quantitation of glucose uptake in tumors by dynamic FDG-PET has less glucose bias and lower variability when adjusted for partial saturation of glucose transport
-
Williams SP, Flores-Mercado JE, Port RE, and Bengtsson T (2012). Quantitation of glucose uptake in tumors by dynamic FDG-PET has less glucose bias and lower variability when adjusted for partial saturation of glucose transport. EJNMMI Res 2, 6.
-
(2012)
EJNMMI Res
, vol.2
, pp. 6
-
-
Williams, S.P.1
Flores-Mercado, J.E.2
Port, R.E.3
Bengtsson, T.4
-
20
-
-
34547841472
-
Plasma and urine pharmacokinetics of niacin and its metabolites from an extended-release niacin formulation
-
Menon RM, Adams MH, González MA, Tolbert DS, Leu JH, and Cefali EA (2007). Plasma and urine pharmacokinetics of niacin and its metabolites from an extended-release niacin formulation. Int J Clin Pharmacol Ther 45, 448-454.
-
(2007)
Int J Clin Pharmacol Ther
, vol.45
, pp. 448-454
-
-
Menon, R.M.1
Adams, M.H.2
González, M.A.3
Tolbert, D.S.4
Leu, J.H.5
Cefali, E.A.6
-
21
-
-
84887050309
-
Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618
-
Xiao Y, Elkins K, Durieux J, Lee L, Oeh J, Lulu Y, Liang X, DelNagro CH, Tremayne J, Kwong M, et al. (2013). Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618. Neoplasia 15, 1151-1160.
-
(2013)
Neoplasia
, vol.15
, pp. 1151-1160
-
-
Xiao, Y.1
Elkins, K.2
Durieux, J.3
Lee, L.4
Oeh, J.5
Lulu, Y.6
Liang, X.7
Delnagro, C.H.8
Tremayne, J.9
Kwong, M.10
-
22
-
-
44449171041
-
Characterization of NAD uptake in mammalian cells
-
Billington RA, Travelli C, Ercolano E, Galli U, Roman CB, Grolla AA, Canonico PL, Condorelli F, and Genazzani AA (2008). Characterization of NAD uptake in mammalian cells. J Biol Chem 283, 6367-6374.
-
(2008)
J Biol Chem
, vol.283
, pp. 6367-6374
-
-
Billington, R.A.1
Travelli, C.2
Ercolano, E.3
Galli, U.4
Roman, C.B.5
Grolla, A.A.6
Canonico, P.L.7
Condorelli, F.8
Genazzani, A.A.9
-
23
-
-
62149150332
-
Niacin status, NAD distribution and ADP-ribose metabolism
-
Kirkland JB (2009). Niacin status, NAD distribution and ADP-ribose metabolism. Curr Pharm Des 15, 3-11.
-
(2009)
Curr Pharm Des
, vol.15
, pp. 3-11
-
-
Kirkland, J.B.1
-
24
-
-
33745817828
-
Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents
-
Khan JA, Tao X, and Tong LA (2006). Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents. Nat Struct Mol Biol 13, 582-588.
-
(2006)
Nat Struct Mol Biol
, vol.13
, pp. 582-588
-
-
Khan, J.A.1
Tao, X.2
Tong, L.A.3
-
25
-
-
84879576402
-
Structure-based identification of ureas as novel nicotinamide phosphoribosyltransferase (Nampt) inhibitors
-
Zheng X, Bauer P, Baumeister T, Buckmelter AJ, Caligiuri M, Clodfelter KH, Han B, Ho YC, Kley N, Lin J, et al. (2013). Structure-based identification of ureas as novel nicotinamide phosphoribosyltransferase (Nampt) inhibitors. J Med Chem 56, 4921-4937.
-
(2013)
J Med Chem
, vol.56
, pp. 4921-4937
-
-
Zheng, X.1
Bauer, P.2
Baumeister, T.3
Buckmelter, A.J.4
Caligiuri, M.5
Clodfelter, K.H.6
Han, B.7
Ho, Y.C.8
Kley, N.9
Lin, J.10
-
26
-
-
0242526050
-
FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis
-
Hasmann M and Schemainda I (2003). FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res 63, 7436-7442.
-
(2003)
Cancer Res
, vol.63
, pp. 7436-7442
-
-
Hasmann, M.1
Schemainda, I.2
|